EVGN.TA

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$2M	-61.6%	$-1.72	$-1.72–$-1.72	—	1
2027	$3M	+75.2%	$-0.81	$-0.81–$-0.81	—	1
2028	$5M	+90.4%	$-0.56	$-0.56–$-0.56	—	1
2029	$8M	+67.7%	$-0.40	$-0.40–$-0.40	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 5 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-18	$-0.80	$-0.42	+48.1%
2026-05-20	$-0.85	$-1.89	-122.2%
2026-03-05	$-0.83	$-1.94	-134.2%
2025-11-20	$-1.36	$1.47	+208.2%
2025-08-19	$-2.13	$-1.69	+20.6%
2025-05-21	$-1.88	$-1.42	+24.8%
2025-03-06	$-2.64	$0.22	+108.3%
2024-11-21	$-1.17

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
EVGN.TAEvogene Ltd.	$158.10	+9.03%	$14M	—
ALMD.TAAllmed Solutions Ltd	$31.30	+0.32%	$30M	—
BLRX.TABioLineRx Ltd.	$1.30	+0.00%	$34M	—
BOLT.TABioLight Life Sciences Ltd.	$295.90	-2.57%	$27M	—
CANF.TACan-Fite BioPharma Ltd.	$348.90

Evogene Ltd.

Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop performance through the development of advanced seed traits, agricultural chemicals, and biological products for crops like corn, soybean, wheat, rice, and cotton. The Human Health division focuses on pioneering microbiome-based treatments for conditions such as immuno-oncology, gastrointestinal ailments, and antibiotic-resistant infections, and also offers medical cannabis products. The Industrial Applications segment is dedicated to developing improved castor bean varieties for various industrial feedstock requirements. Evogene has a global footprint, conducting business in the United States, Israel, Brazil, and other international markets. It maintains significant partnerships, including agricultural collaborations with BASF SE, Corteva, and Bayer, and a medical cannabis development agreement with Cannbit Ltd. through its subsidiary, Canonic Ltd. Established in 1999, Evogene Ltd. is headquartered in Rehovot, Israel.

www.evogene.com

Employees: 52
IPO / List date: Jun 13, 2007
HQ: IL

Held by traders on TradeandTell

No one on the platform currently holds EVGN.TA.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in EVGN.TA as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded EVGN.TA yet.